Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

BioPharm Systems to Host Webinar on How Oracle Argus Safety Migrations Work
  • USA - English


News provided by

BioPharm Systems

Feb 20, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

San Mateo (PRWEB) February 20, 2014 -- Who: Dr. Rodney Lemery, vice president, safety and pharmacovigilance, BioPharm
Richard Higger, founder and president, Valiance Partners

What: Webinar: "How Oracle Argus Safety Migrations Work"

Is your organization considering migrating to Argus Safety, Oracle's comprehensive safety and pharmacovigilance system? Then you probably already know that moving and reformatting legacy adverse event cases can be a major bottleneck.

BioPharm, with their partner, Valiance, can quickly automate and streamline many aspects of the migration and implementation process without resorting to custom scripts, existing APIs, and time-consuming manual tasks. From the assessment and strategy to the complete migration and verification of adverse event cases from your source system (e.g., AERS, ARISg, Excel, Trace, Custom, etc.), leveraging our tried-and-true methodologies and technologies helps you accelerate the entire process with confidence.

Please join BioPharm's Dr. Rodney Lemery and Valiance's Richard Higger for a free one-hour webinar that will explore:

-- The types of risks and challenges associated with safety data system migrations, including migrations related to Japan and other countries
-- How to successfully approach a safety and pharmacovigilance system migration and implementation project
-- The benefits of pre-configured migration software and automated 100% migration testing
-- Examples of past migration and implementation projects
-- Your own migration questions and challenges

When: Thursday, March 20, 2014 at:

8:00 a.m. US Pacific time
9:00 a.m. US Mountain time
10:00 a.m. US Central time
11:00 a.m. US Eastern time
16:00 UK time
17:00 Central European time

Webinar Information: To register for this complimentary webinar, go to: https://cc.readytalk.com/r/c281688i2iki&eom.

BioPharm is a Gold level member of Oracle PartnerNetwork (OPN) and an Oracle Accelerate solution provider. The company has achieved Specializations in Oracle Argus Safety Suite, Oracle Life Sciences Data Hub, and Oracle Accelerate for Midsize Companies.

About Oracle PartnerNetwork

Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners.

About Oracle Accelerate

Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle’s network of expert partners. Oracle Accelerate solutions enable growing midsize organizations to easily adopt Oracle's enterprise class software. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are advanced implementation tools, created and maintained by Oracle. To find out more, visit oracle.com/accelerate.

About BioPharm Systems

BioPharm Systems (http://www.biopharm.com) is a global IT consulting and managed services provider (MSP) that focuses on the life sciences and healthcare industries. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, electronic data capture, and healthcare systems: Siebel Clinical, LabPas, Argus Safety Suite (Argus Safety, Argus Safety Japan, Affiliate, Interchange, Reconciliation, Dossier, Insight, and Perceptive), Adverse Event Reporting System (AERS), Empirica Signal, Empirica Topics, Life Sciences Data Hub (LSH), Clinical Development Analytics (CDA), Data Management Workbench (DMW), Oracle Clinical, Remote Data Capture (RDC), Thesaurus Management System (TMS), and Translational Research Center (TRC), and Healthcare Data Warehouse Foundation (HDWF).

Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm(dot)com.

Trademarks

Oracle and Java are registered trademarks of Oracle and/or its affiliates.

North America Sales Contacts:

Rod Roderick
Vice President of Sales, Trial Management Solutions
rroderick(at)biopharm(dot)com
+1 877 654 0033

Vicky Green
Vice President of Sales, Data Management Solutions
vgreen(at)biopharm(dot)com
+1 877 654 0033

Europe/Middle East/Africa Sales Contact:

Rudolf Coetzee
Director of Business Development, EMEA
rcoetzee(at)biopharm(dot)com
+44 (0) 1865 910200

Communications Contact:

Eugene Sefanov
Marketing Communications Manager
esefanov(at)biopharm(dot)com
+1 617 795 2032

Twitter: twitter.com/BioPharmSystems
Facebook: facebook.com/BioPharmSystems
LinkedIn: linkedin.com/companies/biopharm-systems-inc
YouTube: youtube.com/user/BioPharmSystems
Google Plus: plus.google.com/+biopharm
Pinterest: pinterest.com/biopharmsystems

Eugene Sefanov, BioPharm Systems, http://www.biopharm.com, +1 617 795 2032, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.